Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Chugai Pharmaceutical Invests US$0.35 billion (50 billion Yen) to Open New Manufacturing Facilities
Chugai Pharmaceutical has unveiled its plans to construct a new facility dedicated to the manufacturing of bioactive pharmaceutical ingredients APIs as well as an injection building The two facilities will be loacted in Japan
GenScript Biotech Expands New Manufacturing Facility in China
GenScript Biotech plans for the expansion of new manufacturing facility at Jiangsu, China The facility supports the oligonucleotide and peptide production
TriLink BioTechnologies to Open mRNA Manufacturing Facility
TriLink BioTechnologies plans to construct new mRNA manufacturing capabilities to serve latephase drug developers in the field of life sciences
GeminiBio Plans to Contruct New Liquid Manufacturing Facility
GeminiBio opens new cGMP bioprocess liquid manufacturing facility in California, USA
Meissner Corporation Invests US$250 million to Construct New Manufacturing Facility
Meissner Corporation plans to construct new manufacturing facility The new facility will be loacted at Georgia, USA
Cambrex Constructs New Stability Storage Facility in Belgium, Europe
Cambrex plans to construct new stability storage facility to the pharmaceutical, medical device and life sciences industries across Europe
Catalent Invests US$20 million to Expand in Schorndorf, Germany
Introduction Catalent invests US$20 million to expand its clinical supply facility The new facility will be located in Schorndorf, Germany
PharmaBlock Plans to Expand New R&D Facility Operations in Pennsylvania, USA
PharmaBlock plans to expand its RD operations to deliver GMP projects with the opening of new facility
Pharmaron Invests US$189.79 million (£151 million) to Open New Manufacturing Facility in UK
Pharmaron plans to open a new gene production facility to expand its viral vector and DNA manufacturing facilities to more than 8,000 square metres
Evonik Constructs New Pharmaceutical Lipids Facility in Indiana, USA
Evonik with an investment of US$220 million plans for the construction of new pharmaceutical lipid production facility The new facility will be located in Indiana, United States The new facility is expected to provide industry with access to critical adjuvants needed for mRNA vaccines and other nucleic acid therapies
